首页|[6/6]倍半萜类衍生物的合成及抗肿瘤活性研究

[6/6]倍半萜类衍生物的合成及抗肿瘤活性研究

扫码查看
目的 合成[6/6]倍半萜类衍生物并测试其抗肿瘤活性.方法 以5-氯-1-戊炔和3-甲基-2-环己烯-1-酮为原料,经7步反应,构建了[6/6]倍半萜骨架,再利用酯化反应,得到5个[6/6]倍半萜类衍生物.采用CCK-8法测定目标化合物对人宫颈癌Hela细胞、人非小细胞肺癌A549细胞、人膀胱癌5637细胞的抑制作用.结果 目标化合物对上述3种肿瘤细胞均有抑制作用.其中,化合物Ⅱ对Hela细胞和5637细胞,化合物Ⅰc对A549细胞具有显著的抑制作用,半数抑制浓度分别为17.28、16.99、14.72 μg·mL-1.结论 制备了目标化合物并进行构效关系分析,可为[6/6]倍半萜类抗肿瘤药物的结构优化提供参考.
Synthesis and antitumor activity of[6/6]sesquiterpene derivatives
OBJECTIVE To synthesize[6/6]sesquiterpenoid derivatives and test their antitumor activity.METHODS The[6/6]sesquiterpene skeleton was constructed by a 7 step reaction using 5-chloro-1-pentyne and 3-methyl-2-cyclohexen-1-one as raw materials,and then using esterification reaction,five[6/6]sesquiterpene derivatives were obtained.The inhibitory effects of the target compounds on human cervical cancer Hela cells,human non-small cell lung cancer A549 cells,and human bladder cancer 5637 cells were determined using CCK-8 assay.RESUITS The target compounds showed different degrees of inhibitory effects on the above three types of tumor cells.Among them,compound Ⅱ showed significant inhibitory effects on Hela cells and 5637 cells,and compound Ⅰ c on A549 cells,with IC50 of 17.28,16.99 and 14.72 µg·mL-1,respectively.CONCLUSION The analysis of the conformational relationship results of the target compounds synthesized can provide a reference basis for the structural optimization of the[6/6]sesquiterpene antitumor drugs.

[6/6]sesquiterpenesDerivativesSynthesizeStructural frameworkAntitumor activityADMET calculateEsterificationHuman bladder cancer cells

马永菲、陈晖、李硕、杨秀娟、智怡菱、段国建

展开 >

甘肃中医药大学药学院,甘肃兰州 730000

[6/6]倍半萜 衍生物 合成 结构骨架 抗肿瘤活性 ADMET预测 酯化 人膀胱癌细胞

2024

华西药学杂志
四川大学,四川省药学会

华西药学杂志

CSTPCD北大核心
影响因子:0.624
ISSN:1006-0103
年,卷(期):2024.39(6)